- Home
- SBH vs ANAB Comparison
SBH vs ANAB Comparison
Compare SBH & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBH | ANAB |
|---|---|---|
| Founded | 1964 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2006 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SBH | ANAB |
|---|---|---|
| Price | $13.36 | $62.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 11 |
| Target Price | $17.25 | ★ $74.64 |
| AVG Volume (30 Days) | ★ 1.4M | 614.1K |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.17 | ★ 91.02 |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $3,701,424,000.00 | $234,603,000.00 |
| Revenue This Year | $2.20 | N/A |
| Revenue Next Year | $1.82 | $31.11 |
| P/E Ratio | $29.53 | ★ N/A |
| Revenue Growth | N/A | ★ 157.01 |
| 52 Week Low | $7.54 | $15.40 |
| 52 Week High | $17.92 | $68.39 |
Technical Indicators
Market Signals| Indicator | SBH | ANAB |
|---|---|---|
| Relative Strength Index (RSI) | 39.60 | 56.61 |
| Support Level | $13.28 | $43.67 |
| Resistance Level | $15.75 | $67.69 |
| Average True Range (ATR) | 0.54 | 4.33 |
| MACD | 0.01 | -0.83 |
| Stochastic Oscillator | 39.94 | 60.63 |
Price Performance
Historical ComparisonAbout SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. The company operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, Netherlands, and other geographical regions. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. The products offered by the company include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).